Hepatitis B virus infection and pregnancy: A practical approach

Indian Journal of Gastroenterology

Volumn 31, Issue 2, 2012, Pages 43-54

  Kumar, Ashish ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Antenatal; HBsAg; HBV DNA; Hepatitis B; Pregnancy; Vertical transmission

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; OCTREOTIDE; TELBIVUDINE; TENOFOVIR; VIRUS DNA;

BIRTH DEFECT; BREAST FEEDING; CARCINOGENICITY; CESAREAN SECTION; CHOLESTASIS; CONGENITAL MALFORMATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FETUS MALFORMATION; FETUS OUTCOME; GROWTH DISORDER; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INDIA; INFECTION CONTROL; INFECTION RISK; INTERMETHOD COMPARISON; ISCHEMIA; KIDNEY DYSFUNCTION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; MATERNAL MORBIDITY; MATERNAL MORTALITY; META ANALYSIS (TOPIC); METABOLIC BONE DISEASE; NONHUMAN; POSTPARTUM HEMORRHAGE; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL SCREENING; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCLEROTHERAPY; TREATMENT FAILURE; UTERINE ISCHEMIA; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BREAST FEEDING; FEMALE; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULINS; INDIA; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84862021770     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-012-0174-4     Document Type: Review

References (96)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005; 34 Suppl 1: S1-3.
2. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009; 29 Suppl 1: 133-9.
3. Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl. 2008; 14: 1081-91.
4. Wong S, Chan LY, Yu V, Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol. 1999; 16: 485-8.
5. Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol. 2005; 43: 771-5.
6. Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int. 2010; 30: 765-70.
7. Sheron N, Lau J, Daniels H, et al. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol. 1991; 12: 241-5.
8. Bozkaya H, Bozdayi M, Türkyilmaz R, et al. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology. 2000; 47: 1675-9.
9. Luppi P, Haluszczak C, Trucco M, Deloia JA. Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol. 2002; 47: 72-81.
10. DegliEsposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment. Gastroenterol Clin North Am. 2011; 40: 355-72. viii.
11. Russell MA, Craigo SD. Cirrhosis and portal hypertension in pregnancy. Semin Perinatol. 1998; 22: 156-65.
12. Lee WM. Pregnancy in patients with chronic liver disease. Gastroenterol Clin North Am. 1992; 21: 889-903.
13. Shaheen AAM, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int. 2010; 30: 275-83.
14. Vicari E, Arcoria D, Di Mauro C, Noto R, Noto Z, La Vignera S. Sperm output in patients with primary infertility and hepatitis B or C virus; negative influence of HBV infection during concomitant varicocele. Minerva Med. 2006; 97: 65-77.
15. Huret JL, Jeulin C, Hadchouel M, Scotto J, Molinie C. Semen abnormalities in patients with viral hepatitis B. Arch Androl. 1986; 17: 99-100.
16. Moretti E, Federico MG, Giannerini V, Collodel G. Sperm ultrastructure and meiotic segregation in a group of patients with chronic hepatitis B and C. Andrologia. 2008; 40: 173-8.
17. Kaymakoǧlu S, Okten A, Cakaloǧlu Y, et al. Hypogonadism is not related to the etiology of liver cirrhosis. J Gastroenterol. 1995; 30: 745-50.
18. Englert Y, Lesage B, van Vooren J-P, et al. Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update. 2004; 10: 149-62.
19. Oger P, Yazbeck C, Gervais A, et al. Adverse effects of hepatitis B virus on sperm motility and fertilization ability during IVF. Reprod Biomed Online. 2011; 23: 207-12.
20. Zhou X-P, Hu X-L, Zhu Y-M, Qu F, Sun S-J, Qian Y-L. Comparison of semen quality and outcome of assisted reproductive techniques in Chinese men with and without hepatitis B. Asian J Androl. 2011; 13: 465-9.
21. Gilling-Smith C, Almeida P. HIV, hepatitis B and hepatitis C and infertility: reducing risk. Hum Fertil (Camb). 2003; 6: 106-12.
22. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009; 50: 661-2.
23. Nguyen G, Garcia RT, Nguyen N, Trinh H, Keeffe EB, Nguyen MH. Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther. 2009; 29: 755-64.
24. Potthoff A, Rifai K, Wedemeyer H, Deterding K, Manns M, Strassburg C. Successful treatment of fulminant hepatitis B during pregnancy. Z Gastroenterol. 2009; 47: 667-70.
25. Tan H-H, Lui H-F, Chow W-C. Chronic hepatitis B virus (HBV) infection in pregnancy. Hepatol Int. 2008; 2: 370-5.
26. ACOG Practice Bulletin No. 86. Viral hepatitis in pregnancy. Obstet Gynecol. 2007; 110: 941-56.
27. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis. 1994; 170: 1418-23.
28. Pan CQ, Duan Z, Bhamidimarri KR, et al. An Algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association [Internet]. 2011 Nov 8 [cited 2011 Dec 5]; Available from: http://www. ncbi. nlm. nih. gov/pubmed/22079509.
29. Pande C, Patra S, Kumar A, Sarin S. Giving vaccine alone confers equal protection from chronic hepatitis B infection to neonates born of HBsAg positive mothers as compared to vaccine plus HBIG: A large randomized controlled trial. Hepatology 2010; 52(Suppl): 1008A.
30. Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol. 2001; 184: 1514-8. discussion 1518-20.
31. Xu D-Z, Yan Y-P, Choi BCK, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002; 67: 20-6.
32. Pol S, Corouge M, Fontaine H. Hepatitis B virus infection and pregnancy. Clin Res Hepatol Gastroenterol [Internet]. 2011 Jun 7 [cited 2011 Sep 3]; Available from: http://www. ncbi. nlm. nih. gov/pubmed/21659015.
33. Bai H, Zhang L, Ma L, Dou X-G, Feng G-H, Zhao G-Z. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol. 2007; 13: 3625-30.
34. Pande C, Sakhuja P, Sheetalnath, et al. Hepatitis B can replicate in placental cells leading to transplacental transmission of HBV to the babies (abstract). Indian J Gastroenterol. 2010; 29 Suppl 1: A104.
35. Zhang S-L, Yue Y-F, Bai G-Q, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol. 2004; 10: 437-8.
36. Lin HH, Lee TY, Chen DS, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr. 1987; 111(6 Pt 1): 877-81.
37. Lin HH, Ohto H, Etoh T, Yoneyama T, Kawana T, Mizuno M. Studies on the risk factors of intrauterine infection of hepatitis B virus. Nippon SankaFujinka Gakkai Zasshi. 1985; 37: 2393-400.
38. Moroni GA, Cossu MM, Barbarani V. Vertical transmission of hepatitis B. Boll Ist Sieroter Milan. 1979; 57: 779-85.
39. Yang J, Zeng X, Men Y, Zhao L. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus-a systematic review. Virol J. 2008; 5: 100.
40. Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol. 1980; 87: 958-65.
41. Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities. Korean J Hepatol. 2011; 17: 1-8.
42. Lin HH, Hsu HY, Chang MH, Chen PJ, Chen DS. Hepatitis B virus in the colostra of HBeAg-positive carrier mothers. J Pediatr Gastroenterol Nutr. 1993; 17: 207-10.
43. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol. 2002; 99: 1049-52.
44. Beasley RP, Stevens CE, Shiao IS, Meng HC. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet. 1975; 2: 740-1.
45. Tseng RY, Lam CW, Tam J. Breast feeding babies of HBsAg-positive mothers. Lancet. 1988; 2: 1032.
46. de Martino M, Appendino C, Resti M, Rossi ME, Muccioli AT, Vierucci A. Should hepatitis B surface antigen positive mothers breast feed? Arch Dis Child. 1985; 60: 972-4.
47. Petrova M, Kamburov V. Breast feeding and chronic HBV infection: clinical and social implications. World J Gastroenterol. 2010; 16: 5042-6.
48. Hepatitis_b_and_breastfeeding. pdf [Internet]. [cited 2011 Sep 3]; Available from: http://www. who. int/child_adolescent_health/documents/pdfs/hepatitis_b_and_breastfeeding. pdf.
49. Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011; 18: 468-73.
50. Zhang W-L, Zhao J, Li W. Influencing factors of mother-infant vertical transmission of hepatitis B virus. Zhongguo Dang Dai ErKeZaZhi. 2011; 13: 644-6.
51. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009; 190: 489-92.
52. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975; 292: 771-4.
53. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA. 1985; 253: 1740-5.
54. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol. 1979; 3: 237-41.
55. Zou H, Chen Y, Duan Z, Zhang H. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. PLoS One. 2011; 6: e26748.
56. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990; 87: 6599-603.
57. Xu W-M, Cui Y-T, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009; 16: 94-103.
58. Giles M, Visvanathan K, Sasadeusz J. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. Antivir Ther (Lond). 2011; 16: 621-8.
59. interim_report. pdf [Internet]. [cited 2011 Nov 29]; Available from: http://www. apregistry. com/forms/interim_report. pdf.
60. Han L, Zhang H-W, Xie J-X, Zhang Q, Wang H-Y, Cao G-W. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol. 2011; 17: 4321-33.
61. Hung H-F, Chen H-H. Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection. Pharmacoeconomics. 2011; 29: 1063-73.
62. Unal ER, Lazenby GB, Lintzenich AE, Simpson KN, Newman R, Goetzl L. Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission. Obstet Gynecol. 2011; 118: 655-62.
63. Zhang L-ju, Wang L. Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients. Zhonghua Gan Zang Bing Za Zhi. 2009; 17: 561-3.
64. Han G-R, Cao M-K, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011; 55: 1215-21.
65. Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis. 2010; 14: e622-34.
66. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006; 332: 328-36.
67. Plitt SS, Somily AM, Singh AE. Outcomes from a Canadian public health prenatal screening program for hepatitis B: 1997-2004. Can J Public Health. 2007; 98: 194-7.
68. André FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol. 1994; 44: 144-51.
69. Tharmaphornpilas P, Poovorawan Y, Rasdjarmrearnsook A, Plianpanich S, Sa-nguanmoo P. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine. 2009; 27: 6110-5.
70. Zhu Q, Ge Y, Gu S, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J. 2005; 118: 1604-9.
71. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol. 2006; 7: 241-6.
72. ter Borg MJ, Leemans WF, de Man RA, Janssen HLA. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat. 2008; 15: 37-41.
73. Tagawa H, Suzuki K, Oh S, Kawano M, Fujita A, Yasuhi Y. Influence of pregnancy on HB virus carriers. Nippon Sanka Fujinka Gakkai Zasshi. 1987; 39: 24-30.
74. Lin H-H, Wu W-Y, Kao J-H, Chen D-S. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: correlation with viral characteristics. J Gastroenterol Hepatol. 2006; 21: 605-9.
75. Lodha R, Jain Y, Anand K, Kabra SK, Pandav CS. Hepatitis B in India: a review of disease epidemiology. Indian Pediatr. 2001; 38: 349-71.
76. Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Sytematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007; 44: 663-74.
77. Sandesh K, Varghese T, Harikumar R, et al. Prevalence of hepatitis B and C in the normal population and high risk groups in north Kerala. Trop Gastroenterol. 2006; 27: 80-3.
78. Chatterjee S, Ravishankar K, Chatterjee R, Narang A, Kinikar A. Hepatitis B prevalence during pregnancy. Indian Pediatr. 2009; 46: 1005-8.
79. Pande C, Sarin SK, Patra S, et al. Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India. J Med Virol. 2011; 83: 962-7.
80. Hepatitis B - Home [Internet]. [cited 2011 Dec 5]; Available from: http://www. whoindia. org/en/section6%5Csection8. htm.
81. CIA - The World Factbook [Internet]. [cited 2011 Nov 12]; Available from: https://www. cia. gov/library/publications/the-world-factbook/geos/in. html.
82. Verma R, Khanna P, Prinja S, Rajput M, Chawla S, Bairwa M. Hepatitis B vaccine in national immunization schedule: a preventive step in India. Human Vaccines [Internet]. 2011 Dec 1 [cited 2011 Dec 5]; 7(12). Available from: http://www. ncbi. nlm. nih. gov/pubmed/22134433.
83. Velu V, Nandakumar S, Shanmugam S, Jadhav SS, Kulkarni PS, Thyagarajan SP. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. World J Gastroenterol. 2007; 13: 3084-9.
84. Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol. 2010; 116: 147-59.
85. Khatri JV, Kulkarni KV, Vaishnav PR, Merchant SM. Vertical transmission of hepatitis-B. Indian Pediatr. 1980; 17: 957-62.
86. Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guha DK. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol. 1987; 21: 137-45.
87. Biswas SC, Gupta I, Ganguly NK, Chawla Y, Dilawari JB. Prevalence of hepatitis B surface antigen in pregnant mothers and its perinatal transmission. Trans R Soc Trop Med Hyg. 1989; 83: 698-700.
88. Gupta I, Sehgal A, Sehgal R, Ganguly NK. Vertical transmission of hepatitis B in north India. J Hyg Epidemiol Microbiol Immunol. 1992; 36: 263-7.
89. Mittal SK, Rao S, Rastogi A, Aggarwal V, Kumari S. Hepatitis B-potential of perinatal transmission in India. Trop Gastroenterol. 1996; 17: 190-2.
90. Sharma R, Malik A, Rattan A, Iraqi A, Maheshwari V, Dhawan R. Hepatitis B virus infection in pregnant women and its transmission to infants. J Trop Pediatr. 1996; 42: 352-4.
91. Prakash C, Sharma RS, Bhatia R, Verghese T, Datta KK. Prevalence of North India of hepatitis B carrier state amongst pregnant women. Southeast Asian J Trop Med Public Health. 1998; 29: 80-4.
92. Abass F, Thomas RD, Rajkumar A, Gupta N, Puliyel JM. Controlling perinatally acquired hepatitis B. Indian J Pediatr. 2001; 68: 365.
93. Sahni M, Jindal K, Abraham N, Aruldas K, Puliyel JM. Hepatitis B immunization: cost calculation in a community-based study in India. Indian J Gastroenterol. 2004; 23: 16-8.
94. Varghese RM, Abraham J, James J, Puliyel JM. Determining the point of indifference-where costs of selective and universal immunization against hepatitis B are identical, in a cost-minimization exercise. Indian J Gastroenterol. 2004; 23: 154-6.
95. Banerjee A, Chakravarty R, Mondal PN, Chakraborty MS. Hepatitis B virus genotype D infection among antenatal patients attending a maternity hospital in Calcutta, India: assessment of infectivity status. Southeast Asian J Trop Med Public Health. 2005; 36: 203-6.
96. Dwivedi M, Misra SP, Misra V, et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol. 2011; 30: 66-71.